Pomalidomide?(INN; marketed as?Pomalyst?in the US?and?Imnovid?in the European Union and Russia) is a?derivative?of?thalidomide?marketed by?Celgene. It is anti-angiogenic and also acts as an?immunomodulator.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Pomalidomide industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
1mg Tables
2mg Tables
4mg Tables
Market Segment by Product Application
Hospital
Drug Center
Clinic
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Celgene
Natco Pharma
Intas Pharmaceuticals
Indiabulls Pharmaceutical
Cipla
Glenmark Pharmaceuticals
Dr Reddy's Laboratories
Qilu Pharmaceutical
Chia Tai-Tianqing
Hanson Pharm
Meidakang Huakang Pharmaceutical
Shandong Kongfu Pharmaceutical
SL PHARM
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Pomalidomide consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Pomalidomide market by identifying its various subsegments.
3.Focuses on the key global Pomalidomide manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Pomalidomide with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Pomalidomide submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Pomalidomide Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Pomalidomide Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Pomalidomide Segment by Type
2.1.1 1mg Tables
2.1.2 2mg Tables
2.1.3 4mg Tables
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Drug Center
2.2.3 Clinic
2.2.4 Other
2.3 Global Pomalidomide Market Comparison by Regions (2017-2027)
2.3.1 Global Pomalidomide Market Size (2017-2027)
2.3.2 North America Pomalidomide Status and Prospect (2017-2027)
2.3.3 Europe Pomalidomide Status and Prospect (2017-2027)
2.3.4 China Pomalidomide Status and Prospect (2017-2027)
2.3.5 Japan Pomalidomide Status and Prospect (2017-2027)
2.3.6 Southeast Asia Pomalidomide Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Pomalidomide Industry Impact
2.5.1 Pomalidomide Business Impact Assessment - Covid-19
2.5.2 Market Trends and Pomalidomide Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Pomalidomide Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Pomalidomide Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Pomalidomide Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Pomalidomide Manufacturer Market Share
3.5 Top 10 Pomalidomide Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Pomalidomide Market
3.7 Key Manufacturers Pomalidomide Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Pomalidomide Industry Key Manufacturers
4.1 Celgene
4.1.1 Compan Detail
4.1.2 Celgene Pomalidomide Product Introduction, Application and Specification
4.1.3 Celgene 161 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Celgene News
4.2 Natco Pharma
4.2.1 Compan Detail
4.2.2 Natco Pharma Pomalidomide Product Introduction, Application and Specification
4.2.3 Natco Pharma Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Celgene News
4.3 Intas Pharmaceuticals
4.3.1 Compan Detail
4.3.2 Intas Pharmaceuticals Pomalidomide Product Introduction, Application and Specification
4.3.3 Intas Pharmaceuticals Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Intas Pharmaceuticals News
4.4 Indiabulls Pharmaceutical
4.4.1 Compan Detail
4.4.2 Indiabulls Pharmaceutical Pomalidomide Product Introduction, Application and Specification
4.4.3 Indiabulls Pharmaceutical Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Indiabulls Pharmaceutical News
4.5 Cipla
4.5.1 Compan Detail
4.5.2 Indiabulls Pharmaceutical Pomalidomide Product Introduction, Application and Specification
4.5.3 Cipla Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Cipla News
4.6 Glenmark Pharmaceuticals
4.6.1 Compan Detail
4.6.2 Glenmark Pharmaceuticals Pomalidomide Product Introduction, Application and Specification
4.6.3 Glenmark Pharmaceuticals Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Glenmark Pharmaceuticals News
4.7 Dr Reddy's Laboratories
4.7.1 Compan Detail
4.7.2 Dr Reddy's Laboratories Pomalidomide Product Introduction, Application and Specification
4.7.3 Dr Reddy's Laboratories Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Qilu Pharmaceutical
4.8.1 Compan Detail
4.8.2 Qilu Pharmaceutical Pomalidomide Product Introduction, Application and Specification
4.8.3 Qilu Pharmaceutical Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Qilu Pharmaceutical News
4.9 Chia Tai-Tianqing
4.9.1 Compan Detail
4.9.2 Chia Tai-Tianqing Pomalidomide Product Introduction, Application and Specification
4.9.3 Chia Tai-Tianqing Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Chia Tai-Tianqing News
4.10 Hanson Pharm
4.10.1 Compan Detail
4.10.2 Hanson Pharm Pomalidomide Product Introduction, Application and Specification
4.10.3 Hanson Pharm Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Hanson Pharm News
4.11 Meidakang Huakang Pharmaceutical
4.11.1 Compan Detail
4.11.2 Meidakang Huakang Pharmaceutical Pomalidomide Product Introduction, Application and Specification
4.11.3 Meidakang Huakang Pharmaceutical Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Meidakang Huakang Pharmaceutical News
4.12 Shandong Kongfu Pharmaceutical
4.12.1 Compan Detail
4.12.2 Shandong Kongfu Pharmaceutical Pomalidomide Product Introduction, Application and Specification
4.12.3 Shandong Kongfu Pharmaceutical Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Shandong Kongfu Pharmaceutical News
4.13 SL PHARM
4.13.1 Company Details
4.13.2 SL PHARM Pomalidomide Product Introduction, Application and Specification
4.13.3 SL PHARM Pomalidomide Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 SL PHARM News
5 Global Pomalidomide Market Segment by Big Type
5.1 Global Pomalidomide Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Pomalidomide Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Pomalidomide Revenue and Market Share by Big Type (2017-2022)
5.2 1mg Tables Sales Growth Rate and Price
5.2.1 Global 1mg Tables Sales Growth Rate (2017-2022)
5.2.2 Global 1mg Tables Price (2017-2022)
5.3 2mg Tables Sales Growth Rate and Price
5.3.1 Global 2mg Tables Sales Growth Rate (2017-2022)
5.3.2 Global 2mg Tables Price (2017-2022)
5.4 4mg Tables Sales Growth Rate and Price
5.4.1 Global 4mg Tables Sales Growth Rate (2017-2022)
5.4.2 Global 4mg Tables Price (2017-2022)
6 Global Pomalidomide Market Segment by Big Application
6.1 Global Pomalidomide Sales Market Share by Big Application (2017-2022)
6.2 Hospital Sales Growth Rate (2017-2022)
6.3 Drug Center Sales Growth Rate (2017-2022)
6.4 Clinic Sales Growth Rate (2017-2022)
6.5 Other Sales Growth Rate (2017-2022)
7 Global Pomalidomide Forecast
7.1 Global Pomalidomide Revenue, Sales and Growth Rate (2022-2027)
7.2 Pomalidomide Market Forecast by Regions (2022-2027)
7.2.1 North America Pomalidomide Market Forecast (2022-2027)
7.2.2 Europe Pomalidomide Market Forecast (2022-2027)
7.2.3 China Pomalidomide Market Forecast (2022-2027)
7.2.4 Japan Pomalidomide Market Forecast (2022-2027)
7.2.5 Southeast Asia Pomalidomide Market Forecast (2022-2027)
7.2.6 Other Regions Pomalidomide Market Forecast (2022-2027)
7.3 Pomalidomide Market Forecast by Type (2022-2027)
7.3.1 Global Pomalidomide Sales Forecast by Type (2022-2027)
7.3.2 Global Pomalidomide Market Share Forecast by Type (2022-2027)
7.4 Pomalidomide Market Forecast by Application (2022-2027)
7.4.1 Global Pomalidomide Sales Forecast by Application (2022-2027)
7.4.2 Global Pomalidomide Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Pomalidomide Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Pomalidomide Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Pomalidomide
Figure Market Concentration Ratio and Market Maturity Analysis of Pomalidomide
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Pomalidomide Market Size by Big Type
Figure Global Market Share of Pomalidomide by Big Type in 2021
Figure 1mg Tables Picture (2017-2022)
Figure 2mg Tables Picture (2017-2022)
Global Pomalidomide Market Size by Big Application
Table Global Pomalidomide Market Size by Application
Figure Global Pomalidomide Market Share by Big Application in 2021
Figure Hospital Picture
Figure Drug Center Picture
Figure Clinic Picture
Figure Other Picture
Table Global Pomalidomide Comparison by Regions (M USD) (2017-2027)
Figure Global Pomalidomide Market Size (Million US$) (2017-2027)
Figure North America Pomalidomide Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Pomalidomide Revenue (Million US$) Growth Rate (2017-2027)
Figure China Pomalidomide Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Pomalidomide Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Pomalidomide Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Pomalidomide Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Pomalidomide Sales by Manufacturer (2017-2022)
Figure Global Pomalidomide Sales Market Share by Manufacturer in 2021
Table Global Pomalidomide Revenue by Manufacturer (2017-2022)
Figure Global Pomalidomide Revenue Market Share by Manufacturer in 2021
Table Global Pomalidomide Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Pomalidomide Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Pomalidomide Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Pomalidomide Market
Table Key Manufacturers Pomalidomide Product Type
Table Mergers & Acquisitions Planning
Table Celgene Company Profile
Table Pomalidomide Product Introduction, Application and Specification of Celgene
Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Natco Pharma Company Profile
Table Pomalidomide Product Introduction, Application and Specification of Natco Pharma
Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Natco Pharma Recent Development
Table Intas Pharmaceuticals Company Profile
Table Pomalidomide Product Introduction, Application and Specification of Intas Pharmaceuticals
Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Intas Pharmaceuticals Main Business
Table Intas Pharmaceuticals Recent Development
Table Indiabulls Pharmaceutical Company Profile
Table Pomalidomide Product Introduction, Application and Specification of Indiabulls Pharmaceutical
Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Indiabulls Pharmaceutical Main Business
Table Indiabulls Pharmaceutical Recent Development
Table Indiabulls Pharmaceutical Main Business
Table Indiabulls Pharmaceutical Recent Development
Table Cipla Company Profile
Table Pomalidomide Product Introduction, Application and Specification of Cipla
Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cipla Main Business
Table Cipla Recent Development
Table Glenmark Pharmaceuticals Company Profile
Table Pomalidomide Product Introduction, Application and Specification of Glenmark Pharmaceuticals
Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Glenmark Pharmaceuticals Main Business
Table Glenmark Pharmaceuticals Recent Development
Table Dr Reddy's Laboratories Company Profile
Table Pomalidomide Product Introduction, Application and Specification of Dr Reddy's Laboratories
Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Dr Reddy's Laboratories Main Business
Table Dr Reddy's Laboratories Recent Development
Table Qilu Pharmaceutical Company Profile
Table Pomalidomide Product Introduction, Application and Specification of Qilu Pharmaceutical
Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Qilu Pharmaceutical Main Business
Table Qilu Pharmaceutical Recent Development
Table Chia Tai-Tianqing Company Profile
Table Pomalidomide Product Introduction, Application and Specification of Chia Tai-Tianqing
Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Chia Tai-Tianqing Main Business
Table Chia Tai-Tianqing Recent Development
Table Hanson Pharm Company Profile
Table Pomalidomide Product Introduction, Application and Specification of Hanson Pharm
Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Hanson Pharm Main Business
Table Hanson Pharm Recent Development
Table Meidakang Huakang Pharmaceutical Company Profile
Table Pomalidomide Product Introduction, Application and Specification of Meidakang Huakang Pharmaceutical
Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Meidakang Huakang Pharmaceutical Main Business
Table Meidakang Huakang Pharmaceutical Recent Development
Table Shandong Kongfu Pharmaceutical Company Profile
Table Pomalidomide Product Introduction, Application and Specification of Shandong Kongfu Pharmaceutical
Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Shandong Kongfu Pharmaceutical Main Business
Table Shandong Kongfu Pharmaceutical Recent Development
Table SL PHARM Company Profile
Table Pomalidomide Product Introduction, Application and Specification of SL PHARM
Table Pomalidomide Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table SL PHARM Main Business
Table SL PHARM Recent Development
Figure Global Pomalidomide Sales and Growth Rate (2017-2022)
Figure Global Pomalidomide Revenue and Growth Rate (2017-2022)
Table Global Pomalidomide Sales by Regions (2017-2022)
Figure Global Pomalidomide Sales Market Share by Regions in 2021
Table Global Pomalidomide Revenue by Regions (2017-2022)
Figure Global Pomalidomide Revenue Market Share by Regions in 2021
Figure North America Pomalidomide Sales and Growth Rate (2017-2022)
Figure Europe Pomalidomide Sales and Growth Rate (2017-2022)
Figure China Pomalidomide Sales and Growth Rate (2017-2022)
Figure Japan Pomalidomide Sales and Growth Rate (2017-2022)
Figure Southeast Asia Pomalidomide Sales and Growth Rate (2017-2022)
Figure Other Regions Pomalidomide Sales and Growth Rate (2017-2022)
Table Global Pomalidomide Sales by Big Type (2017-2022)
Table Global Pomalidomide Sales Market Share by Big Type (2017-2022)
Figure Global Pomalidomide Sales Market Share by Big Type in 2019
Table Global Pomalidomide Revenue by Big Type (2017-2022)
Table Global Pomalidomide Revenue Market Share by Big Type (2017-2022)
Table Global Pomalidomide Revenue Market Share by Big Type in 2019
Figure Global 1mg Tables Sales Growth Rate (2017-2022)
Figure Global 1mg Tables Price (2017-2022)
Figure Global 2mg Tables Sales Growth Rate (2017-2022)
Figure Global 2mg Tables Price (2017-2022)
Figure Global 4mg Tables Sales Growth Rate (2017-2022)
Table Global Pomalidomide Sales by Big Application (2017-2022)
Table Global Pomalidomide Sales Market Share by Big Application (2017-2022)
Figure Global Pomalidomide Sales Market Share by Big Application in 2019
Figure Global Hospital Sales Growth Rate (2017-2022)
Figure Global Drug Center Sales Growth Rate (2017-2022)
Figure Global Clinic Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Pomalidomide Sales and Growth Rate (2022-2027)
Figure Global Pomalidomide Revenue and Growth Rate (2022-2027)
Table Global Pomalidomide Sales Forecast by Regions (2022-2027)
Table Global Pomalidomide Market Share Forecast by Regions (2022-2027)
Figure North America Sales Pomalidomide Market Forecast (2022-2027)
Figure Europe Sales Pomalidomide Market Forecast (2022-2027)
Figure China Sales Pomalidomide Market Forecast (2022-2027)
Figure Japan Sales Pomalidomide Market Forecast (2022-2027)
Figure Southeast Asia Sales Pomalidomide Market Forecast (2022-2027)
Figure Other Regions Sales Pomalidomide Market Forecast (2022-2027)
Table Global Pomalidomide Sales Forecast by Type (2022-2027)
Table Global Pomalidomide Market Share Forecast by Type (2022-2027)
Table Global Pomalidomide Sales Forecast by Application (2022-2027)
Table Global Pomalidomide Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pomalidomide
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Pomalidomide Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Pomalidomide Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Pomalidomide Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Pomalidomide Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Pomalidomide Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Pomalidomide Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Pomalidomide Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Pomalidomide Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Celgene
Natco Pharma
Intas Pharmaceuticals
Indiabulls Pharmaceutical
Cipla
Glenmark Pharmaceuticals
Dr Reddy's Laboratories
Qilu Pharmaceutical
Chia Tai-Tianqing
Hanson Pharm
Meidakang Huakang Pharmaceutical